Ten days after cancer cell inoculation, significantly higher IL6 concentration was observed in mice bearing MOC2 tumors than in mice bearing TC-1 tumors (Fig. 4A), confirming the bioinformatic results (Fig. 2). The gene discussed is IL6; the disease is cancer.